Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы

Nargiza Parpieva

Работ: 49

University College London

  1. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

    Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis +15

    СтатьяTuberculosis Research and EpidemiologyNew England Journal of Medicine2022Цитирований: 5
    ABI

  2. Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study

    Jamshid Gadoev, Damin Asadov, Mirzagolib Tillashaykhov +14

    СтатьяTuberculosis Research and EpidemiologyPLoS ONE2015Цитирований: 4
    ABI

  3. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

    Shona Horter, Beverley Stringer, Jane Greig +5

    СтатьяTuberculosis Research and EpidemiologyBMC Infectious Diseases2016Цитирований: 4
    ABI

  4. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

    James M. Trauer, Jay Achar, Nargiza Parpieva +7

    СтатьяTuberculosis Research and EpidemiologyBMC Medicine2016Цитирований: 3
    ABI

  5. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

    Shona Horter, Beverley Stringer, Nell Gray +5

    СтатьяTuberculosis Research and EpidemiologyBMC Infectious Diseases2020Цитирований: 3
    ABI

  6. Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan

    Parvati Nair, T. Hasan, K. K. Zaw +9

    СтатьяTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease2022Цитирований: 3
    ABI

  7. ‘They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan

    Beverley Stringer, Karen Lowton, Mirzagaleb N. Tillashaikhov +5

    СтатьяTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease2016Цитирований: 2
    ABI

  8. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018

    Khasan Safaev, Nargiza Parpieva, Irina Liverko +5

    СтатьяTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health2021Цитирований: 2
    ABI

  9. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?

    Sharofiddin Yuldashev, Nargiza Parpieva, Salikhdjan Alimov +6

    СтатьяTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health2021Цитирований: 2
    ABI

  10. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

    Johanna Kuhlin, Chris Smith, Atadjan Khaemraev +8

    СтатьяTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease2018Цитирований: 1
    ABI

  11. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

    S.K. Abidi, Jay Achar, M.M. Assao Neino +34

    СтатьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2019Цитирований: 1
    ABI

  12. Population structure of drug-resistant Mycobacterium tuberculosis in Central Asia

    A. Engström, Uladzimir Antonenka, Abdylat Kadyrov +10

    СтатьяTuberculosis Research and EpidemiologyBMC Infectious Diseases2019Цитирований: 1
    ABI

  13. Treatment Compliance of Multidrug Resistant Tuberculosis in Uzbekistan: Does Practice Follow Policy?

    Ruzilya Usmanova, Nargiza Parpieva, Hayk Davtyan +6

    СтатьяTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health2021Цитирований: 1
    ABI

  14. Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis

    Aleksandr Trubnikov, Arax Hovhannesyan, Kristina Akopyan +5

    СтатьяTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health2021Цитирований: 1
    ABI

  15. Risk Factors for Unfavorable Treatment Outcomes among the Human Immunodeficiency Virus-Associated Tuberculosis Population in Tashkent City, Uzbekistan: 2013–2017

    Sherali Massavirov, Kristina Akopyan, Fazlkhan Abdugapparov +5

    СтатьяTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health2021Цитирований: 1
    ABI

  16. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

    Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

    СтатьяTuberculosis Research and EpidemiologyERJ Open Research2020Цитирований: 1
    ABI

  17. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

    Shona Horter, Jay Achar, Nell Gray +4

    СтатьяTuberculosis Research and EpidemiologyPLoS ONE2020Цитирований: 1
    ABI

  18. Diagnostic Procedures, Diagnoses, and Treatment Outcomes of Patients with Presumptive Tuberculosis Pleural Effusion in Uzbekistan

    Fazlkhan Abdugapparov, Ruzanna Grigoryan, Nargiza Parpieva +7

    СтатьяPleural and Pulmonary DiseasesInternational Journal of Environmental Research and Public Health2021Цитирований: 1
    ABI

  19. [Features of disruption of certain components of carbohydrate metabolism in a combination of pulmonary tuberculosis and diabetes mellitus in people with haptoglobin phenotypes].

    Nargiza Parpieva, K S Kazakov

    СтатьяErythrocyte Function and PathophysiologyPubMed2001Цитирований: 0
    ABI

  20. Mutations in the genes of drug-resistant mycobacterium tuberculosis in Uzbekistan

    Nargiza Parpieva, Vera Beloserkoves, Khasan Safaev +1

    СтатьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2014Цитирований: 0
    ABI

  21. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen

    Jay Achar, Catherine Berry, Krzysztof Herboczek +7

    ДругоеTuberculosis Research and EpidemiologyEmerging infectious diseases2015Цитирований: 0
    ABI

  22. Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan

    Jamshid Gadoev, Damin Asadov, Anthony Harries +9

    СтатьяTuberculosis Research and EpidemiologyPLoS ONE2017Цитирований: 0
    ABI

  23. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study

    Mathieu Bastard, Elisabeth Sánchez-Padilla, Philipp du Cros +12

    СтатьяTuberculosis Research and EpidemiologyPLoS ONE2018Цитирований: 0
    ABI

  24. Surgical approach in multi- and extensively drug-resistant tuberculosis: resection and thoracomioplasty

    Askar Zetov, Kulakhmed Erimbetov, Nargiza Parpieva +2

    СтатьяTuberculosis Research and EpidemiologyElectronic Journal of General Medicine2019Цитирований: 0
    ABI

  25. The center for distance learning and monitoring in education of tb specialists and medical students

    Sanajr Sultanov, Nargiza Parpieva, Kozim Mukhamedov

    СтатьяEconomic and Industrial Development2019Цитирований: 0
    ABI